ATE116322T1 - Kristallines cefadroxil und verfahren zu dessen herstellung. - Google Patents
Kristallines cefadroxil und verfahren zu dessen herstellung.Info
- Publication number
- ATE116322T1 ATE116322T1 AT88100478T AT88100478T ATE116322T1 AT E116322 T1 ATE116322 T1 AT E116322T1 AT 88100478 T AT88100478 T AT 88100478T AT 88100478 T AT88100478 T AT 88100478T AT E116322 T1 ATE116322 T1 AT E116322T1
- Authority
- AT
- Austria
- Prior art keywords
- cefadroxyl
- novel
- production
- solvate
- cefadroxil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pyrrole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878709804A GB8709804D0 (en) | 1987-04-24 | 1987-04-24 | Crystalline cefadroxil |
GB878718394A GB8718394D0 (en) | 1987-08-04 | 1987-08-04 | Crystalline cefadroxil hemihydrate |
US07/089,168 US4904776A (en) | 1987-04-24 | 1987-08-25 | Method for producing crystalline cefadroxil hemihydrate |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE116322T1 true ATE116322T1 (de) | 1995-01-15 |
Family
ID=27263404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88100478T ATE116322T1 (de) | 1987-04-24 | 1988-01-14 | Kristallines cefadroxil und verfahren zu dessen herstellung. |
Country Status (13)
Country | Link |
---|---|
US (1) | US4904776A (de) |
EP (1) | EP0287751B1 (de) |
JP (1) | JP2620582B2 (de) |
CN (1) | CN1019804B (de) |
AT (1) | ATE116322T1 (de) |
AU (1) | AU595415B2 (de) |
DE (1) | DE3852560T2 (de) |
DK (1) | DK13888A (de) |
ES (1) | ES2068812T3 (de) |
FI (1) | FI87569C (de) |
PH (1) | PH26292A (de) |
PT (1) | PT86653B (de) |
SU (1) | SU1630613A3 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714180D0 (en) * | 1987-06-17 | 1987-07-22 | Rifar Srl | Anhydrous crystalline cefadroxil |
WO1991000865A1 (en) * | 1989-07-10 | 1991-01-24 | Gema S.A. | A novel stable form of cephradine, process for its production and intermediates used therein |
IN190389B (de) | 1999-07-14 | 2003-07-26 | Ranbaxy Lab Ltd | |
AU5418300A (en) * | 1999-07-14 | 2001-01-30 | Ranbaxy Laboratories Limited | Process for preparing crystalline cefadroxil hemihydrate from cefadroxil dimethylformamide solvate |
CN1311830C (zh) * | 2004-02-27 | 2007-04-25 | 石药集团中奇制药技术(石家庄)有限公司 | 头孢羟氨苄口腔崩解片及其制备方法 |
KR101420451B1 (ko) * | 2006-05-19 | 2014-07-16 | 디에스엠 시노켐 파마슈티칼스 네덜란드 비.브이. | 세파드록실의 결정화 방법 |
CN102134250B (zh) * | 2011-01-19 | 2013-03-13 | 天津大学 | 一种头孢羟氨苄单水合物的结晶方法及结晶 |
CN104447795B (zh) * | 2014-11-28 | 2016-08-17 | 珠海金鸿药业股份有限公司 | 一种头孢羟氨苄化合物及其药物组合物 |
CN105534937B (zh) * | 2015-12-30 | 2019-12-03 | 石药集团欧意药业有限公司 | 一种头孢羟氨苄片剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1532682A (en) * | 1976-04-27 | 1978-11-22 | Bristol Myers Co | Process for the preparation of cephadroxil |
US4504697A (en) * | 1982-04-28 | 1985-03-12 | Littelfuse, Inc. | Sealed electrical devices |
-
1987
- 1987-08-25 US US07/089,168 patent/US4904776A/en not_active Expired - Fee Related
-
1988
- 1988-01-13 DK DK013888A patent/DK13888A/da not_active Application Discontinuation
- 1988-01-14 DE DE3852560T patent/DE3852560T2/de not_active Expired - Fee Related
- 1988-01-14 ES ES88100478T patent/ES2068812T3/es not_active Expired - Lifetime
- 1988-01-14 EP EP88100478A patent/EP0287751B1/de not_active Expired - Lifetime
- 1988-01-14 AT AT88100478T patent/ATE116322T1/de not_active IP Right Cessation
- 1988-01-14 AU AU10285/88A patent/AU595415B2/en not_active Ceased
- 1988-01-28 PT PT86653A patent/PT86653B/pt not_active IP Right Cessation
- 1988-02-02 JP JP63022670A patent/JP2620582B2/ja not_active Expired - Lifetime
- 1988-02-15 SU SU884355195A patent/SU1630613A3/ru active
- 1988-03-07 FI FI881038A patent/FI87569C/fi not_active IP Right Cessation
- 1988-04-04 PH PH36729A patent/PH26292A/en unknown
- 1988-04-06 CN CN88101895A patent/CN1019804B/zh not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI87569B (fi) | 1992-10-15 |
EP0287751A3 (en) | 1990-05-02 |
FI881038A0 (fi) | 1988-03-07 |
CN88101895A (zh) | 1988-11-30 |
ES2068812T3 (es) | 1995-05-01 |
DK13888A (da) | 1988-10-25 |
PT86653A (pt) | 1988-02-01 |
JP2620582B2 (ja) | 1997-06-18 |
US4904776A (en) | 1990-02-27 |
EP0287751A2 (de) | 1988-10-26 |
AU1028588A (en) | 1988-10-27 |
DE3852560D1 (de) | 1995-02-09 |
FI87569C (fi) | 1993-01-25 |
AU595415B2 (en) | 1990-03-29 |
FI881038A (fi) | 1988-10-25 |
DK13888D0 (da) | 1988-01-13 |
DE3852560T2 (de) | 1995-05-04 |
JPS63267789A (ja) | 1988-11-04 |
PT86653B (pt) | 1992-07-31 |
PH26292A (en) | 1992-04-10 |
EP0287751B1 (de) | 1994-12-28 |
CN1019804B (zh) | 1992-12-30 |
SU1630613A3 (ru) | 1991-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE135712T1 (de) | Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung | |
DE3382299D1 (de) | Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung. | |
ATE116322T1 (de) | Kristallines cefadroxil und verfahren zu dessen herstellung. | |
DE3789810D1 (de) | Verfahren zur Herstellung von kristallinem Cefadroxilmonohydrat. | |
ATE32071T1 (de) | Cyclohexenonderivate, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses. | |
ATE18226T1 (de) | Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
ATE78257T1 (de) | Im wesentlichen wasserfreies kristallines cefadroxil und verfahren zu dessen herstellung. | |
PT79118B (de) | Cephalosporinderivate und verfahren zur ihrer herstellung | |
ATE38515T1 (de) | Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung. | |
ATE36853T1 (de) | Beta-carbolin-3-carbonsaeurederivate und methode zu ihrer herstellung. | |
JPS5746990A (en) | Novel cephalexin derivative and its preparation | |
DE3777464D1 (de) | Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung. | |
ATE25680T1 (de) | Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten. | |
ATE127774T1 (de) | Verfahren zur herstellung von bicyclo(3.2.0)hept- 2-en-7-onen. | |
ATE29253T1 (de) | Verfahren zur herstellung von 4-chinolinonen. | |
ATE98248T1 (de) | Verfahren zur herstellung von cephalosporinderivaten. | |
ATE24718T1 (de) | Alkylcycloalkyl-imidazolylmethyl-ketone und verfahren zu ihrer herstellung. | |
ATE92028T1 (de) | Verfahren zur herstellung von oxyessigsaeure/hydroxyethyletherverbindung. | |
JPS5515419A (en) | Novel oxabicyclo(3,2,1)-octane derivative and its preparation | |
JPS56139494A (en) | Cephamycin derivative and its preparation | |
ES8101602A1 (es) | Un procedimiento para la preparacion de analogos de cefalos-porina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |